Table 3. Trait differences between subarachnoid and ventricular neurocysticercosis.
Subarachnoid neurocysticercosis N = 114 |
Ventricular neurocysticercosis N = 63 |
P | |
---|---|---|---|
Age at diagnosis | 44.2 ± 11.8 | 36.2 ± 12.0 | < 0.0001 |
Sex (male) | 62 (54.4) | 29 (46.0) | 0.29 |
Symptoms | |||
Headache | 34 (29.8) | 13 (20.6) | 0.18 |
Seizures | 31 (27.2) | 8 (12.7) | 0.03 |
ICH | 73 (64.0) | 46 (73.0) | 0.22 |
Focal deficit | 20 (17.5) | 6 (9.5) | 0.15 |
Psychiatric | 3 (2.6) | 0 (0.0) | 0.55 |
Asymptomatic lacunar infarcts | 17 (27.0) | 7 (36.8) | 0.40 |
Lumbar CSF characteristics | |||
Cells (/mL) | 116.3 ± 187.9 | 49.1 ± 59.8 | 0.001 |
Protein concentration (mg/dL) | 166.6 ± 238.6 | 86.6 ± 114.1 | 0.005 |
Glycorrhachia (mg/dL) | 42.5 ± 25.3 | 56.2 ± 24.6 | 0.001 |
Antibodies | 88 (97.8) | 41 (85.4) | 0.009 |
Antigens | 55 (85.9) | 14 (50.0) | < 0.0001 |
Degenerating stage of parasites | |||
Vesicular only | 91 (79.8) | 41 (65.1) | 0.04 |
Single | 6 (6.6) | 22 (53.6) | < 0.0001 |
Degenerating only | 2 (1.7) | 17 (27.0) | < 0.0001 |
Single | 0 (0) | 10 (58.8) | 0.21 |
Vesicular + degenerating | 21 (18.4) | 5 (7.9) | 0.08 |
Association with Parenchymal calcification | 49 (43.0) | 29 (46.0) | 0.70 |